Vision Financial Markets’s Pacira BioSciences PCRX Stock Holding History

Vision Financial Markets’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.5K	Hold	100	–	–	﹤0.01%	323
2026 Q1	$2.26K	Hold	100	–	–	﹤0.01%	330
2025 Q4	$2.59K	Hold	100	–	–	﹤0.01%	306
2025 Q3	$2.58K	Hold	100	–	–	﹤0.01%	329
2025 Q2	$2.39K	Hold	100	–	–	﹤0.01%	323
2025 Q1	$2.48K	Buy	+100	New	+$2.39K	﹤0.01%	299

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vision Financial Markets's PCRX Position: Q2 2026 in Review

Vision Financial Markets held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 100 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

Vision Financial Markets first reported a position in PCRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.59K in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Vision Financial Markets held 100 shares of Pacira BioSciences worth $2.5K as of Q2 2026.
Vision Financial Markets left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Vision Financial Markets's portfolio in Q2 2026, its #323 holding.
Vision Financial Markets first reported a position in Pacira BioSciences in Q1 2025 and has held it in 6 quarters since.
Vision Financial Markets's Pacira BioSciences position peaked at $2.59K in Q4 2025.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.